First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Presented by: Tammy Bradly, VP Clinical Product Development
After a year of immense change, the United States continues to battle the COVID-19 pandemic and the opioid crisis.
Each year, thousands of employees sustain on-the-job facial or eye injuries from accidents that could have been prevented with the proper selection
San Diego, CA—Mitchell | Genex |Coventry, a leader in cost containment technology, provider networks, clinical services, pharmacy
Network Evolution Today, we see constructive partnerships between providers and payers that include a wide variety of provider types and